New research on Coeliac Disease

Today, scientists at the Walter & Eliza Hall Institute of Medical Research have announced a breakthrough in the study of a possible treatment for Coeliac Disease. Dr Bob Anderson and his team from Australia and the UK, have identified three toxic peptide components of gluten which seem to be responsible for the majority of problems. A drug company is already developing an immunotherapy which works by exposing people with coeliac disease to small amounts of the three toxic peptides and is based upon the same principles as desensitisation for allergies.

Anderson's research is published in today's issue of Science Translational Medicine. You can read about it on the website of the Walter and Eliza Hall Institute or in their media release today.